0001756702-18-000001.txt : 20181024 0001756702-18-000001.hdr.sgml : 20181024 20181024143702 ACCESSION NUMBER: 0001756702-18-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20181024 DATE AS OF CHANGE: 20181024 EFFECTIVENESS DATE: 20181024 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Castle Creek Pharmaceutical Holdings, Inc. CENTRAL INDEX KEY: 0001756702 IRS NUMBER: 831984773 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-324223 FILM NUMBER: 181136218 BUSINESS ADDRESS: STREET 1: 6 CENTURY DRIVE, 2ND FLOOR CITY: PARSIPPANY STATE: NJ ZIP: 07054 BUSINESS PHONE: 847-715-0606 MAIL ADDRESS: STREET 1: 6 CENTURY DRIVE, 2ND FLOOR CITY: PARSIPPANY STATE: NJ ZIP: 07054 D 1 primary_doc.xml X0708 D LIVE 0001756702 Castle Creek Pharmaceutical Holdings, Inc. 6 CENTURY DRIVE, 2ND FLOOR PARSIPPANY NJ NEW JERSEY 07054 847-715-0606 DELAWARE None None Corporation true 2018 Patrick Morris c/o Castle Creek Pharmaceutical Holdings 6 Century Drive, 2nd Floor Parsippany NJ NEW JERSEY 07054 Executive Officer Director President, Secretary and Treasurer Michael Derby c/o Castle Creek Pharmaceutical Holdings 6 Century Drive, 2nd Floor Parsippany NJ NEW JERSEY 07054 Executive Officer Director Chief Executive Officer Antonio Gracias c/o Castle Creek Pharmaceutical Holdings 6 Century Drive, 2nd Floor Parsippany NJ NEW JERSEY 07054 Director Timothy Cunniff c/o Castle Creek Pharmaceutical Holdings 6 Century Drive, 2nd Floor Parsippany NJ NEW JERSEY 07054 Director Jeffrey Aronin c/o Castle Creek Pharmaceutical Holdings 6 Century Drive, 2nd Floor Parsippany NJ NEW JERSEY 07054 Director Pharmaceuticals Decline to Disclose 06b false 2018-10-09 false true false 0 Octagon Capital Group, LLC 173341 None None 45 Essex Street Suite 204 Millburn NJ NEW JERSEY 07041 CT CONNECTICUT IL ILLINOIS MA MASSACHUSETTS NJ NEW JERSEY NY NEW YORK PA PENNSYLVANIA false 560544226 560544226 0 Total offering disclosed consists of: (a) shares of Series B Preferred Stock sold for $71,799,458 cash & (b) Series A Preferred Stock issued in exchange for membership interests in Castle Creek Pharmaceuticals, LLC, with an estimated value of $488,744,768 false 19 1217994 0 0 false Castle Creek Pharmaceutical Holdings, Inc. Patrick Morris Patrick Morris President 2018-10-23